EICHORCondition: Fibromyalgia · Sponsor: Axsome Therapeutics, Inc.
This is a Phase 3, multi-center, 52-week, open-label trial to evaluate the long-term safety and efficacy of AXS-14 in the management of fibromyalgia.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Clinical Research Site | Arkansas City, Arkansas, United States | — |
| Clinical Research Site | Redlands, California, United States | — |
| Clinical Research Site | Sacramento, California, United States | — |
| Clinical Research Site | Santa Ana, California, United States | — |
| Clinical Research Site | Jacksonville, Florida, United States | — |
| Clinical Research Site | Orlando, Florida, United States | — |
| Clinical Research Site | Tampa, Florida, United States | — |
| Clinical Research Site | Atlanta, Georgia, United States | — |
| Clinical Research Site | Norcross, Georgia, United States | — |
| Clinical Research Site | Chicago, Illinois, United States | — |
| Clinical Research Site | Overland Park, Kansas, United States | — |
| Clinical Research Site | Louisville, Kentucky, United States | — |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07637162